Center for Pharmacogenomics, Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, 1004 Biomedical Research Tower, 460 W 12th Avenue, Columbus, OH, USA.
Center for Happiness Studies, Seoul National University, Gwanak-gu, Gwanak-ro 1, Bldg. 220, Seoul, 151-746, South Korea.
BMC Genomics. 2018 Nov 20;19(1):826. doi: 10.1186/s12864-018-5219-3.
The CHRNA5/A3/B4 gene locus is associated with nicotine dependence and other smoking related disorders. While the non-synonymous CHRNA5 variant rs16969968 appears to be the main risk factor, linkage disequilibrium (LD) bins in the gene cluster carry frequent variants that regulate expression. Pairwise LD and haplotype analyses had identified at least three haplotype tagging SNPs including rs16969968 as main genetic risk factors. Searching for variants with evidence of regulatory functions, we have reported interactions between CHRNA5 and CHRNA3 enhancer variants (tagged by rs880395 and rs1948, respectively) and rs16969968, forming 3-SNP haplotypes and diplotypes that may more accurately reflect the cluster's combined effects on nicotine dependence (Barrie et al., Hum Mutat 38:112-9, 2017). Here we address further contributions by variants affecting CHRNB4, a possibly limiting component of nicotinic receptors.
We identify an LD bin (tagged by rs4887074) associated with expression of CHRNB4. Additive logistic regression models indicate that rs4887074 is associated with nicotine dependence and modulates the effect of rs16969968 in GWAS datasets (COGEND, UW-TTURC, SAGE). 4-SNP haplotype and diplotype analyses (rs880395-rs16969968-rs1948 -rs4887074) yield nicotine dependence risk values that further differentiate those obtained with the 3-SNP model. Moreover, both the main G allele of rs16969968 and the minor G allele of rs4887074 (associated with reduced expression of CHRNB4), residing predominantly on common haplotypes that are protective, represent significant allele-specific variance QTLs, indicating that they interact with each other.
These results indicate rs4887074 is associated with CHRNB4 expression, and along with two regulatory variants of CHRNA3 and CHRNA5, modulates the effect of rs16969968 on nicotine dependence risk. Assignable to individuals because of strong LD structures, 4-SNP haplotypes and diplotypes serve to assess the combined genetic influence of this multi-gene cluster on complex traits, accounting for complex LD relationships and tissue-specific genetic effects (CHRNA5/3) relevant to the traits analyzed. The 4-SNP haplotypes account at least in part for previous tagging SNPs, including the highly GWAS-significant rs6495308, located in a distinct pair-wise LD bin but included in protective 4-SNP haplotypes. Our approach refines and integrates the cluster's overall genetic influence, an important variable when integrating the genetics of multiple genomic loci.
CHRNA5/A3/B4 基因座与尼古丁依赖和其他与吸烟相关的疾病有关。虽然非 synonymous CHRNA5 变体 rs16969968 似乎是主要的风险因素,但基因簇中的连锁不平衡(LD)bins 携带调节表达的常见变体。成对 LD 和单倍型分析已经确定了至少三个单倍型标记 SNP,包括 rs16969968 作为主要的遗传风险因素。在寻找具有调节功能证据的变体时,我们报告了 CHRNA5 和 CHRNA3 增强子变体(分别由 rs880395 和 rs1948 标记)与 rs16969968 之间的相互作用,形成了 3-SNP 单倍型和二倍型,这可能更准确地反映了该基因簇对尼古丁依赖的综合影响(Barrie 等人,Hum Mutat 38:112-9, 2017)。在这里,我们进一步研究了影响 CHRNB4 的变体的作用,CHRNB4 是烟碱型乙酰胆碱受体的一个可能的限制成分。
我们确定了一个与 CHRNB4 表达相关的 LD bin(由 rs4887074 标记)。加性逻辑回归模型表明,rs4887074 与尼古丁依赖有关,并调节 GWAS 数据集中 rs16969968 的效应(COGEND、UW-TTURC、SAGE)。4-SNP 单倍型和二倍型分析(rs880395-rs16969968-rs1948-rs4887074)产生的尼古丁依赖风险值进一步区分了 3-SNP 模型获得的风险值。此外,rs16969968 的主要 G 等位基因和 rs4887074 的次要 G 等位基因(与 CHRNB4 表达降低有关),主要存在于保护性的常见单倍型上,代表着显著的等位基因特异性方差 QTL,表明它们相互作用。
这些结果表明 rs4887074 与 CHRNB4 的表达有关,与 CHRNA3 和 CHRNA5 的两个调节变体一起,调节 rs16969968 对尼古丁依赖风险的影响。由于强 LD 结构,可归因于个体的 4-SNP 单倍型和二倍型用于评估这个多基因簇对复杂性状的综合遗传影响,考虑到与所分析的性状相关的复杂 LD 关系和组织特异性遗传效应(CHRNA5/3)。4-SNP 单倍型至少部分解释了之前的标记 SNP,包括高度 GWAS 显著的 rs6495308,位于不同的成对 LD bin 中,但包含在保护性的 4-SNP 单倍型中。我们的方法细化和整合了该基因簇的整体遗传影响,这是整合多个基因组位点遗传信息时的一个重要变量。